Landscape of Biomarkers in Non-small Cell Lung Cancer Using Comprehensive Genomic Profiling and PD-L1 Immunohistochemistry

Comprehensive genomic profiling (CGP) and immunohistochemistry (IHC) are important biomarker tools used for patients with non-small cell lung cancer (NSCLC) given the expanding number of standard-of-care therapies that require companion diagnostic testing. We examined 9450 NSCLC real-world patient s...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Richard S. P., Severson, Eric, Haberberger, James, Duncan, Daniel L., Hemmerich, Amanda, Edgerly, Claire, Ferguson, N. Lynn, Frampton, Garrett, Owens, Clarence, Williams, Erik, Elvin, Julia, Vergilio, Jo-Anne, Killian, Jonathan Keith, Lin, Douglas, Morley, Samantha, McEwan, Deborah, Holmes, Oliver, Danziger, Natalie, Cohen, Michael B., Sathyan, Pratheesh, McGregor, Kimberly, Reddy, Prasanth, Venstrom, Jeffrey, Anhorn, Rachel, Alexander, Brian, Brown, Charlotte, Ross, Jeffrey S., Ramkissoon, Shakti H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Society Journal Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262230/
https://www.ncbi.nlm.nih.gov/pubmed/34257540
http://dx.doi.org/10.3389/pore.2021.592997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262230/
https://www.ncbi.nlm.nih.gov/pubmed/34257540
http://dx.doi.org/10.3389/pore.2021.592997

Ejemplares similares